(DIR) Return Create A Forum - Home --------------------------------------------------------- MS Speaks (HTM) https://msspeaks.createaforum.com --------------------------------------------------------- ***************************************************** (DIR) Return to: TREATMENTS ***************************************************** #Post#: 4366-------------------------------------------------- (Abst.) DMTs in pediatric-onset MS By: agate Date: March 29, 2024, 11:10 am --------------------------------------------------------- These authors advocate the use of high-efficacy DMTs--[font=blinkmacsystemfont]alemtuzumab, cladribine, daclizumab, fingolimod, mitoxantrone, natalizumab, ocrelizumab, rituximab, or autologous hematopoietic stem cell transplantation--[/font]in persons diagnosed with MS between the ages of 15 and 24. From PubMed (March 29, 2024)--"Disease-modifying therapies in managing disability worsening in pediatric-onset multiple sclerosis: A longitudinal analysis of global and national registries": (HTM) https://pubmed.ncbi.nlm.nih.gov/38547883/ *****************************************************